What Are the Challenges in Targeting Alternative Splicing in Cancer?
Despite its potential, targeting alternative splicing in cancer presents several challenges. One major issue is the complexity and redundancy of the splicing machinery, making it difficult to achieve specificity. Additionally, the systemic effects of modulating splicing can lead to unintended consequences in normal tissues. Therefore, a deep understanding of the splicing landscape and careful design of therapeutic interventions are crucial for success.
